XML 33 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS
The table below summarizes certain asset and liability fair values that are included within our accompanying Consolidated Balance Sheets, and their designations among the three fair value measurement categories (see Note 2(xiii)):
 
December 31, 2018
Fair Value Measurements
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Assets:

 

 

 

 
Bank certificates of deposits
$

 
$
86

 
$

 
$
86

 
Money market funds

 
142,745

 

 
142,745

 
Equity securities (Note 11)
46,422

 

 

 
46,422

 
Mutual funds

 
78

 

 
78

 
Deferred compensation investments (life insurance cash surrender value - Note 3(h))

 
6,274

 

 
6,274

*

$
46,422

 
$
149,183

 
$

 
$
195,605

 
Liabilities:

 

 

 

 
Deferred executive compensation liability (Note 17(f))

 
6,167

 

 
6,167

*
FOLOTYN development liability (Note 16)

 

 
11,997

 
11,997

 
Talon CVR (Note 10 (a))

 

 
4,345

 
4,345

 

$

 
$
6,167

 
$
16,342

 
$
22,509

 
 
 
December 31, 2017
Fair Value Measurements
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Assets:

 

 

 

 
Bank certificates of deposits
$

 
$
248

 
$

 
$
248

 
Money market funds

 
216,358

 

 
216,358

 
Equity securities (Note 11)
37,530

 

 

 
37,530

 
Mutual funds

 
59

 

 
59

 
Deferred compensation investments (life insurance cash surrender value - Note 3(h))

 
14,887

 

 
14,887

*

$
37,530

 
$
231,552

 
$

 
$
269,082

 
Liabilities:

 

 

 

 
Deferred executive compensation liability (Note 17(f))

 
11,038

 

 
11,038

*
FOLOTYN development liability (Note 16)

 

 
12,386

 
12,386

 
Talon CVR (Note 10 (a))

 

 
6,210

 
6,210

 
Corixa Liability (Note 17(b)(i))

 

 
62

 
62

 

$

 
$
11,038

 
$
18,658

 
$
29,696

 

* The reported amount of “deferred compensation investments” is based on the cash surrender value of employee life insurance policies at period-end, while the reported amount of “deferred executive compensation liability” is based on the period-end market value of investments selected by plan participants.
We did not have any transfers between “Level 1” and “Level 2” (see Note 2(xiii)) measurement categories for any periods presented.
The table below summarizes the 2017 and 2018 activity of our liabilities that are valued with unobservable inputs:

Fair Value Measurements of
Unobservable Inputs
(
Level 3)
 
Balance at December 31, 2016
$
14,445

 
FOLOTYN development liability (Note 16)
(744
)
 
Talon CVR fair value adjustment - MARQIBO (Note 10(a))
4,957

 
Balance at December 31, 2017
$
18,658

 
FOLOTYN development liability (Note 16)
(389
)
 
Talon CVR fair value adjustment - MARQIBO (Note 10(a))
(1,865
)
 
Corixa Liability (Note 17(b)(i))
(62
)
 
Balance at December 31, 2018
$
16,342



Our carrying amounts of financial instruments such as cash equivalents, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, excluding acquisition-related contingent obligations, approximate their related fair values due to their short-term nature.